Skip to content
  1. Home
  2. >Clinical Genomics
  3. >Pharmacogenomics
  4. >Pgx Level A Panel
Back to catalog

Pharmacogenomics (PGx) Level A Panel

Turnaround

6-9 days

Turnaround Requery

≤ 5 minutes

Test Description

This test evaluates a patient’s metabolizer status for 16 genes, which can aid in appropriate medication selection and dosing to reduce risk of side effects and treatment failure for cancer, cardiovascular disease, pain, mental health and other conditions. All results in this test are based on CPIC Level A guidance, but this test is not comprehensive for all CPIC Level A guidance.

View the complete description of this test
Sample report

Have Questions?

Our team is available Monday through Friday, 9am-5pm Pacific Time.

(844) 211 2070clinicalsupport@helix.com

Genes Tested

ABCG2
CYP2D6
CYP2C19
CYP2C9
CYP3A5
CYP4F2
DPYD
HLA-B
IFNL3
IFNL4
MT-RNR1
NUDT15
SLCO1B1
TPMT
UGT1A1
VKORC1

Showing 16 of 16 genes in this panel

Other Tests to Consider

Test

Malignant Hyperthermia Susceptibility Panel

3

genes

Test

Pharmacogenomics (PGx) APOE Test

1

gene

Test

Pharmacogenomics (PGx) Fluoropyrimidines DPYD Test

1

gene

Test

Pharmacogenomics (PGx) Pain Panel

7

genes

Important Test Information

Turnaround time: Typically 7-10 days (standard), Typically < 5 minutes (requery)

Preferred specimen: BD Vacutainer Whole Blood K2 EDTA Collection Tube 4mL or Oragene Dx Saliva Collection Kit

Shipping Instructions: Specimens to arrive at Helix within 96 hours of collection at ambient temperature.

All detected variants are evaluated according to the Clinical Pharmacogenetics Implementation Consortium (CPIC). Variants are classified based on known, predicted, or possible impact on drug metabolism.